Congress moves to lock in contraceptive access, overriding state bans

What it does

This bill creates a federal statutory right to access contraceptives and for health care providers to supply them, contraception, and related information without government restriction. It bars federal and state laws that single out or impede contraceptive access, and allows individuals and providers to sue in federal court to block such restrictions, with attorney's fees awarded to prevailing plaintiffs.

Why we flagged it

The bill's operative mechanism is a direct statutory right to contraceptive access and provider protection, enforced through private litigation and federal preemption of state restrictions. This is a rights-based public health measure, not a regulatory carve-out or subsidy.

What the text implies

• Abrogates state sovereign immunity under the Tenth and Eleventh Amendments, allowing individuals to sue states directly in federal court without state consent—a significant federalism shift that may invite constitutional challenge.
• The 'clear and convincing evidence' standard for defending restrictions is unusually high and may effectively bar most state-level limitations, even those with public health or safety rationales.
• Explicitly overrides the Religious Freedom Restoration Act (RFRA) for contraceptive access, preventing religious exemptions that might otherwise shield providers or employers—a direct collision with RFRA's protections.
• Defines 'government officials' to include private individuals permitted by law to implement restrictions (e.g., state legislators, pharmacy boards), expanding the class of defendants and potential liability.
• The bill's preemption language ('applies notwithstanding any other provision of Federal law') may conflict with existing federal programs (e.g., conscience protections in federal health programs) and create litigation over scope.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill expands access to a health care service and removes barriers to obtaining it, while also protecting provider autonomy to offer care. It creates enforceable private rights and federal oversight to prevent state-level restrictions, strengthening individual reproductive autonomy and health care access.

Who stands to gain

• pharmaceutical manufacturers (contraceptive drugs and devices)
• medical device companies (IUDs, implants)
• health care providers and clinics offering contraceptive services
• pharmacies dispensing contraceptives

Named in the bill

U.S. House of Representatives, Committee on Energy and Commerce, Department of Health and Human Services (HHS), Food and Drug Administration (FDA), States (as defendants), Health care providers (physicians, nurse-midwives, nurses, nurse practitioners, physician assistants, Medicaid program, Patient Protection and Affordable Care Act (ACA), Religious Freedom Restoration Act (RFRA), Bristol Myers Squibb (BMY), Genmab (GH), Pfizer (PFE) — and 2 more

Where it stands

211 cosponsors: 210 Democrats, 1 Republicans.

• Feb 5, 2025 — Introduced · Congress.gov: “Introduced in House”
• Feb 5, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

9 lobbying clients named this bill on 13 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $2,671,784 in lobbying spend. A filing names 48 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 89% of bills with at least one filing.

Lizzie Fletcher, the sponsor, reported $693,505 in PAC receipts in the 2026 cycle.

• American Academy of Family Physicians — $1,715,904 on 2 filings
• Planned Parenthood Federation of America Inc — $652,972 on 1 filing
• Hadassah, the Women's Zionist Organization of America, Inc. — $120,000 on 2 filings
• Planned Parenthood Action Fund Inc — $79,708 on 1 filing
• Power to Decide — $33,451 on 2 filings

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.